Clinical Trial Detail

NCT ID NCT00625378
Title Sorafenib Long Term Extension Program (STEP)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bayer
Indications

Advanced Solid Tumor

Therapies

Sorafenib

Age Groups: adult

No variant requirements are available.